Immunological detection of a novel advanced glycation end-product.
BACKGROUND
The advanced stage of the Maillard reaction that leads to the formation of advanced glycation end-products (AGEs) plays an important role in the pathogenesis of angiopathy in diabetic patients and in the aging process. Recently, it has been proposed that the intermediates contributing to AGE formation include dicarbonyl intermediates such as glyoxal, methylglyoxal, and 3-deoxyglucosone (3-DG). In the present study, we developed a novel, non-carboxymethyllysine (CML) anti-AGE antibody that recognizes serum proteins and peptides modified by 3-DG in vivo.


METHODS
AGE-modified serum albumins were prepared by incubation of rabbit serum albumin with 3-DG or D-glucose. After immunization of rabbits, anti-AGE antisera were subjected to affinity chromatography on a Sepharose 4B column coupled with CML-BSA, or AGE-BSA created by incubation with 3-DG (AGE-6) or D-glucose (AGE-1). The AGE-Ab-6 and AGE-Ab-1 thus obtained was used to investigate AGEs in serum from diabetic patients on hemodialysis.


RESULTS
Characterization of the novel AGE-Ab-6 obtained by immunoaffinity chromatography was performed with a competitive ELISA and immunoblot analysis. This antibody specifically cross-reacted with proteins modified by 3-DG. AGE-6 was detected in diabetic serum as three peaks with apparent molecular weights of 200, 1.15, and 0.85 kD, while AGE-1 was detected as four peaks with apparent molecular weights of 200, 65, 1.15, and 0.85 kD.


CONCLUSIONS
This study provides new data on the pathways of AGE formation from 3-DG and methods for the immunochemical detection of AGEs. We also provide immunochemical evidence for the existence of six distinct AGEs in vivo among the AGE-modified proteins and peptides in the serum of diabetic patients on hemodialysis.
Takeuchi
M
M
Department of Biochemistry, Faculty of Pharmaceutical Science, Hokuriku University, Kanazawa, Japan. m-takeuchi@hokuriku-u.ac.jp
Yanase
Y
Y
Matsuura
N
N
Yamagishi Si
S
S
Kameda
Y
Y
Bucala
R
R
Makita
Z
Z
D000818:Animals; D003847:Deoxyglucose / Q000031:analogs & derivatives* / Q000737:chemistry; D017127:Glycation End Products, Advanced / Q000032:analysis* / Q000737:chemistry / Q000276:immunology; D006801:Humans; D007118:Immunoassay; D011499:Protein Processing, Post-Translational; D011817:Rabbits
D017127:Glycation End Products, Advanced; D003847:Deoxyglucose; C016350:3-deoxyglucosone